【基石药业-B(02616.HK)首次披露两款自身免疫/炎症性疾病全新双抗分子靶点】智通财经APP讯,基石药业-B(02

智通财经
Yesterday
【基石药业-B(02616.HK)首次披露两款自身免疫/炎症性疾病全新双抗分子靶点】智通财经APP讯,基石药业-B(02616.HK)发布公告,公司首次披露两款自主研发、针对自身免疫/炎症性疾病的双特异性抗体药物靶点:

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10